Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000874015-04-000083
Filing Date
2004-12-16
Accepted
2004-12-16 17:13:08
Documents
1
Period of Report
2004-12-14

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 4220
  Complete submission text file 0000874015-04-000083.txt   6018
Mailing Address 2292 FARADAY AVE CARLSBAD CA 92008
Business Address 2292 FARADAY AVE CARLSBAD CA 92008 7609319200
ISIS PHARMACEUTICALS INC (Issuer) CIK: 0000874015 (see all company filings)

EIN.: 330336973 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address INDIANA UNIVERSITY, CHEMSITRY A508 800 EAST KIRKWOOD BLOOMINGTON IN 47405
Business Address 812-856-1840
DiMarchi Richard D (Reporting) CIK: 0001311733 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19125 | Film No.: 041208980